Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,044 | 16 | 83.9% |
| Consulting Fee | $200.00 | 1 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $772.86 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $220.71 | 2 | $0 (2024) |
| Gilead Sciences Inc | $106.29 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $61.06 | 2 | $0 (2024) |
| United Therapeutics Corporation | $34.35 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $29.94 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $19.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $953.58 | 13 | Actelion Pharmaceuticals US, Inc. ($652.80) |
| 2023 | $64.29 | 2 | United Therapeutics Corporation ($34.35) |
| 2018 | $120.06 | 1 | Actelion Pharmaceuticals US, Inc. ($120.06) |
| 2017 | $106.29 | 1 | Gilead Sciences Inc ($106.29) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $97.63 | General |
| 11/07/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $130.74 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $98.57 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Cardio-pulmonary | ||||||
| 06/19/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $145.92 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $33.58 | General |
| 05/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Cardio-pulmonary | ||||||
| 01/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $114.11 | General |
| Category: Cardiology | ||||||
| 01/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Cardiology | ||||||
| 01/24/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Cardiology | ||||||
| 12/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: PAH | ||||||
| 11/07/2018 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $120.06 | General |
| 04/20/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $106.29 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 74 | 134 | $39,318 | $13,488 |
| 2022 | 5 | 135 | 204 | $59,862 | $23,224 |
| 2021 | 3 | 78 | 127 | $43,362 | $16,452 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 38 | $20,444 | $6,210 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 59 | $12,067 | $4,232 | 35.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 23 | $3,929 | $2,093 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $2,878 | $953.04 | 33.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 38 | 63 | $32,256 | $10,846 | 33.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 63 | $10,470 | $4,780 | 45.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $5,178 | $2,428 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 29 | $5,091 | $2,132 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 15 | $3,675 | $1,680 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 18 | $3,192 | $1,358 | 42.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 35 | 59 | $30,208 | $10,038 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 30 | 55 | $9,020 | $4,399 | 48.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $4,134 | $2,016 | 48.8% |
About Dr. Meghan Cirulis, M.D
Dr. Meghan Cirulis, M.D is a Internal Medicine healthcare provider based in Murray, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1649690744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meghan Cirulis, M.D has received a total of $1,244 in payments from pharmaceutical and medical device companies, with $953.58 received in 2024. These payments were reported across 17 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,044).
As a Medicare-enrolled provider, Cirulis has provided services to 287 Medicare beneficiaries, totaling 465 services with total Medicare billing of $53,164. Data is available for 3 years (2021–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Murray, UT
- Active Since 04/16/2014
- Last Updated 03/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649690744
Products in Payments
- OPSUMIT (Drug) $375.23
- Adempas (Drug) $220.71
- UPTRAVI (Drug) $179.94
- TYVASO (Drug) $34.35
- XARELTO (Drug) $29.94
- WINREVAIR (Biological) $27.48
- AIRSUPRA (Drug) $19.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Murray
Danette Ko, Md, MD
Internal Medicine — Payments: $79,359
Dr. Divya Ratan Verma, Md, MD
Internal Medicine — Payments: $45,795
Alissa Kauffman, Md, MD
Internal Medicine — Payments: $31,001
Vivian Lee, Md, MD
Internal Medicine — Payments: $15,734
Dr. David Fedor, D.o, D.O
Internal Medicine — Payments: $15,117
Lucinda Bateman, Md, MD
Internal Medicine — Payments: $11,412